Lung Cancer Screening in High-risk Black Individuals
Evaluating the Feasibility of Lung Cancer Screening in High-risk Black Individuals
Who can join
As published by the study on ClinicalTrials.gov. "Not stated" means the study hasn't said — ask the study team.
- Age
- 50 Years to 80 Years
- Sex
- All sexes
- Healthy volunteers
- Accepted
- Compensation
- Not stated
Other requirements are listed under Eligibility below. Only the study team can confirm whether you can join.
What to expect
No one can promise a trial will help you personally — that is what the research is trying to find out.
What participation involves
- Time periods mentioned: 3 months
- Procedures mentioned: CT scans, Questionnaires
Only what the study's summary and detailed description on ClinicalTrials.gov say. Time periods may describe the whole study or a part of it — ask the study team what applies to you.
Show the study's own words
- "The name of the intervention used in this research study is: Low-dose computed tomography (radiologic scan) chest scan"
- "The goal of this single-arm pilot research study is to evaluate the feasibility and acceptability of low-dose computed tomography (LDCT) screening for lung cancer among U.S."
- "Study procedures include screening for eligibility, completion of questionnaires, and a LDCT screening test."
- "Participation in this study is expected to last up to 3 months."
- Compensation
- Not stated
- Study-related exams and procedures are typically provided at no cost. This is how many trials work in general — confirm the details for this study with the study team.
- Participants are monitored closely by the research team throughout the study.
- Some participants may receive access to an investigational treatment, which is still being studied.
- Your participation helps researchers learn whether this approach could help future patients.
About this study
In plain language
This study looks at lung cancer screening with a low-dose CT scan, a chest scan that uses a small amount of radiation. It is for Black adults in the U.S., ages 50–80, who have smoked. The study checks how practical the screening is, how people feel about it, and how well it works.
The goal of this research study is to study U.S. Black individuals with a history of smoking to examine the feasibility, acceptability, and performance of low-dose computed tomography (LDCT) screening among this population. The name of the intervention used in this research study is: Low-dose computed tomography (radiologic scan) chest scan
Compensation is read from the study's own description and may be missing — always confirm with the study team.
Eligibility
Who can join
- Identify as Black.
- Are 50–80 years old.
- Report having smoked. There is no minimum amount you must have smoked and no limit on how long ago you quit.
Who can't join
- Have ever had lung cancer.
- Report shortness of breath, getting winded easily, or a cough during the past 12 weeks that has not improved. An online survey will check for these symptoms. If you report any of them, you cannot join and will be advised to see your regular doctor.
- Had pneumonia or another recent breathing infection treated with antibiotics within 12 weeks before joining.
Simplified for readability. The official criteria below are what the study team uses.
Official eligibility criteria
Inclusion Criteria: * Self-identified Black individual. * Have a self-reported history of smoking. No restriction will be placed on the number of smoking pack years participants must have nor the number of years former smokers must have quit smoking. * Aged 50-80 years. Exclusion Criteria: * Individuals with a history of lung cancer. * Individuals with symptoms suggestive of lung cancer. We will evaluate whether individuals have symptoms suggestive of lung cancer by administering an online screening questionnaire, which will ask whether they have experienced shortness of breath, whether they become easily winded, and whether they have had a chronic cough within the last 12 weeks that has not improved. Individuals who select that they have any one of these symptoms will be advised to follow up with their primary doctor and will not be eligible to participate in the study. * Individuals with pneumonia or acute respiratory infection within 12 weeks prior to enrollment that was treated with antibiotics.
Study sites (2)
IL
- University of Chicago · Chicago, IL 60637Jessica Donington, MD · Study contact · 773-834-6121 · jdonington@surgery.bsd.uchicago.eduMore trials in Chicago
MA
- Massachusetts General Hospital Cancer Center · Boston, MA 02215Chi Fu Jeffrey Yang, MD · Study contact · 617-724-1681 · cjyang@mgh.harvard.eduMore trials in Boston